Novo Nordisk says it plans to apply for regulatory approval of its sickle cell disease, etavopivat, in the second half of ...
Novo Nordisk will be happy with the results after Pfizer has dropped two SCD assets in recent years. Credit: JHVEPhoto / ...
After six weeks in the hospital, 23‑year‑old Daniel Cressy leaves with hope for a functional cure and a future where he can ...
Topline data for the once-daily PKR activator etavopivat demonstrate a 27% reduction in vaso-occlusive crises and a robust hematologic response in patients with SCD.
Dr. Swee Lay Thein and Dr. Stuart Orkin won the $3 million Breakthrough Prize in Life Sciences for their work toward a ...
Negative descriptors were present in 15% of notes for sickle cell patients; 14% of notes for patients with opioid use ...
Female adolescents and adults with sickle cell disease are at risk for a range of menstrual complications, especially pain and abnormal uterine bleeding. That’s according to the authors of a new multi ...
LOS ANGELES (KABC) -- It's been more than a month since the FDA approved two milestone gene-editing treatments for sickle cell disease, but lining up patients for these therapies will be a challenge ...
"We need effective anti-bias interventions to improve care for patients with sickle cell disease, and this deeper understanding is a step in the right direction," said the study author.
Sickle cell disease advocates in East Texas say raising awareness and expanding education are critical steps toward improving care and saving lives. Despite being the most common inherited blood ...
Andrea Matthews poses with her son Jonathan Matthews. She started the foundation because her son lives with sickle cell disease. Michelle Parr's sickle cell disease went undiagnosed for 25 years. Her ...
Despite data gaps in many countries, the burden of sickle cell disease, especially in west and central Africa, underscores ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results